ALFA Filings
Every announcement, straight from the exchange
Every earnings call announcement on NSE and BSE that our alert engine sent, newest first.
Time
7,037 announcements
Niva Bupa reported strong Q1 FY27 results with 31.7% reported growth and PAT improving to INR 137.8 crores. Management focused on retail health expansion and transition to Ind AS accounting.
DLF Limited Q1FY27 results show strong cash flow with INR 1,317 cr OCF and a net cash position of INR 15,200 cr. Strategy focuses on high-margin luxury launches and expanding the annuity rental portfolio.
Sportking India reports robust revenue growth and margin expansion despite a minor fire incident, driven by stable raw material prices and strong capacity utilization.
Torrent Power reported Q1 FY27 revenue of ₹8,124 Cr (+3% YoY) with PAT of ₹662 Cr. Strategy focuses on expanding renewable capacity and pumped storage hydro projects.
Vishnu Chemicals delivered strong 25% revenue and 23% PAT growth in Q1FY27, driven by strategic shifts toward high-value chromium derivatives and expanding barium/strontium operations despite global logistics headwinds.
Fabtech turned profitable in Q1 FY27, reporting revenue of ₹74.98 Cr and PAT of ₹4.21 Cr. Strategy shifts toward high-margin Saudi and African EPC markets.
Strides Pharma Science reported Q1 FY27 results with 13% YoY revenue growth and EBITDA margins maintained at 18.2%. Strategy focuses on Ex-US growth and US portfolio diversification.
Avadh Sugar reported Q1FY27 revenue growth of 9% YoY and EBITDA growth of 34%, with PAT turning positive compared to a loss in Q1FY26. Strategy focuses on distillery integration and value-added sugar.
Nucleus Software reports Q1 FY27 consolidated revenue of INR 210.4 Cr (up 3.4% YoY) with an EBITDA of INR 7.6 Cr. Strategy focuses on AI-embedded products and expanding global market footprint.
GPT Healthcare reported Q1FY27 revenue of ₹126.2 Cr, up 17.8% YoY, with EBITDA margins improving to 20.4%. The company is executing a proximity-based model in Eastern India.
Q1FY27 was a mixed quarter with volume missing expectations due to energy crises and UAE disruptions, but EBITDA per ton remained resilient due to pricing power.
Exide Q1 FY27 results show strong core lead-acid growth alongside milestone customer samples from the new lithium-ion gigafactory. Management remains optimistic but avoids specific numerical guidance for the new lithium business.
Kansai Nerolac reports Q1 FY27 results, focusing on 'Paint+' product strategy, network expansion, and technology leadership in industrial coatings.
LatentView faced a revenue miss in Q1 FY27 due to insourcing at a major tech client and lumpiness in CPG project work, but management maintains its 12% full-year growth guidance.
RBA reports Q1 FY27 results with consolidated revenue growing 17.9% YoY to INR 8,226 Mn. India SSSG hit a 15-quarter high of 12.6%.
Glenmark delivered robust 23.1% revenue growth for Q1 FY27, driven by strong recovery in North America and steady India outperformance, despite persistent geopolitical cost pressures.
GPT Infraprojects reported stable Q1FY27 performance despite temporary execution delays in West Bengal due to elections. Management remains bullish on a 30% revenue growth target for FY27, driven by high-margin signaling and power EPC segments.
CAMS reported Q1 FY27 revenue of ₹395 Cr with an EBITDA margin of 46.4%. Strategy focuses on core MF dominance and rapid non-MF diversification (now 14.9% of revenue).
GSK India delivered strong Q1 FY27 standalone performance with revenue growing 15% and PAT up 24%, driven by portfolio transformation and core brand leadership.
Tata Chemicals reports Q1FY27 consolidated revenue growth of 14% YoY. Management is restructuring reporting into Living, Industrial, and Farm Essentials to focus on non-cyclical, sustainability-led products.
RR Kabel delivered record Q1 FY27 results with revenue of ₹3,168 Cr (+54% YoY) and EBITDA of ₹285 Cr (+100% YoY). Segmental transformation saw FMEG reaching operational breakeven for the first time.
Ather reported strong Q1 FY27 growth with total income reaching ₹1,216.92 Cr (+89% YoY) and turning EBITDA positive at 1% margin.
Trident Lifeline (TLL) achieved ₹129 Cr consolidated revenue in FY26, a 48% increase. Strategy centers on a demand-led manufacturing model and aggressive global registration expansion.
Q1 FY27 revenue grew 6.3% YoY to ₹187 Cr. Management focused on moving up the fluorochemical value chain with the ₹395 Cr HFC-32 project and expanding solar-grade DHF capacity.
UPL reported Q1FY27 revenue of ₹10,181 cr (+10% YoY) and EBITDA of ₹1,500 cr (+15% YoY). Strategy focuses on margin expansion, reaching a 14.7% EBITDA margin.
Blue Jet Healthcare reported Q1 FY27 Revenue of ₹2,931mn, up 25% QoQ but down 17.4% YoY. Strategy focuses on expanding R&D and CDMO adjacencies.
Pine Labs reported 20% YoY Q1 growth with a PAT of Rs.20 Crores. Management is shifting to a lighter balance sheet by selling terminals upfront.
Q1FY27 revenue and profitability declined sharply due to delayed monsoon and price competition. Management is pivoting towards new product launches and a ₹200-crore capex for a manufacturing plant in Nagpur.
NOCIL reported strong Q1FY27 performance with 20% YoY revenue growth. Strategy focuses on 'China + 1' tailwinds and product portfolio expansion via the new TDQ facility.
Escorts Kubota delivered strong Q1FY27 standalone performance with Revenue up 28% YoY to ₹3,178.9 Cr and PAT up 26% YoY. Strategy focuses on Kubota synergy and product expansion.